Table 4.
Hazard ratio associated with 5-year survival in patients with oral and oropharyngeal squamous cell carcinomas treated at the A.C. Camargo Cancer Center, Hospital Cancer Registry, 2001–2012.
| Oral cavity | Oropharynx | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Group | HRunadjusted (95%CI) | p value | HRadjusted (95%CI) | p value | HRunadjusted (95%CI) | p value | HRadjusted (95%CI) | p value |
| Period | 2001-2006 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 2007-2012 | 0.90 (0.70-1.17) | 0.443 | 0.91 (0.70-1.18) | 0.487 | 0.70 (0.53-0.92) | 0.012 | 0.69 (0.52-0.92) | 0.012 | |
| Gender | Female | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Male | 1.20 (0.91-1.58) | 0.189 | 1.14 (0.86-1.51) | 0.360 | 1.03 (0.69-1.52) | 0.885 | 0.94 (0.63-1.39) | 0.747 | |
| Age group (yrs) | ≤50 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| 51-60 | 1.27 (0.87-1.87) | 0.213 | 1.05 (0.71-1.55) | 0.807 | 1.36 (0.91-2.05) | 0.136 | 1.46 (0.97-2.20) | 0.073 | |
| >60 | 1.60 (1.14-2.24) | 0.007 | 1.42 (1.01-2.01) | 0.044 | 1.80 (1.22-2.65) | 0.003 | 1.88 (1.27-2.78) | 0.002 | |
| Clinical stage | I-II | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| III-IV | 3.66 (2.68-5.00) | <0.001 | 3.58 (2.61-4.89) | <0.001 | 3.10 (1.59-6.04) | 0.001 | 3.23 (1.65-6.30) | 0.001 | |
*HR, hazard ratio.